期刊文献+

3种无创检查在前列腺癌初筛诊断中的应用价值 被引量:6

Three kinds of noninvasive screening application in diagnosis of early prostate cancer
暂未订购
导出
摘要 目的:研究直肠指检(DRE)、经直肠超声检查(TRUS)及多参数磁共振成像(MP-MRI)在前列腺癌诊断的应用价值。方法回顾分析113例临床疑似前列腺癌患者数据。结果所有疑似前列腺癌患者中,DRE的灵敏度为33.3%,特异度为88.7%;TRUS的灵敏度为62.7%,特异度为67.7%;MP-MRI的灵敏度为86.3%,特异度为83.9%。3组间两两比较差异均具有统计学意义(P<0.05)。在 PSA 4.0~10.0 ng/mL的 PSA灰区疑似前列腺癌患者中,DRE的灵敏度为27.8%,特异度为86.5%;TRUS的灵敏度为44.4%,特异度为59.5%;MP-MRI的灵敏度为77.8%,特异度为81.1%。3组间两两比较差异均具有统计学意义(P<0.05)。结论 MP-MRI在前列腺癌诊断中表现出了较好的检测效能,并能减少灰区前列腺癌的漏诊,具有重要价值。 Objective To evaluate the effect of noninvasive diagnosis methods direct rectal examination (DRE) ,transrectal ultra-sonography(TRUS) and multiparametric magnetic resonance imaging(MP-MRI) for prostate cancer detection .Methods The clini-cal data of 113 patients suspected prostatic cancer were analyzed retrospectively .Every patient was examined by TRUS ,DRE and MP-MRI before pathology or operation .The sensitivity rate and the specificity rate of DRE ,TRUS and MP-MRI were calculated and compared among the three methods .Results The sensitivity rate and the specificity rate of prostate cancer were 33 .3% and 88 .7% for DRE ,62 .7% and 67 .7% for TRUS ,86 .3% and 83 .9% for MP-MRI respectively ,two comparison between the three group had statisfically difference(P〈0 .05) .But ,of prostate cancer with prostate specific antigen (PSA) 4 .0~10 .0 ng/mL in gray zone ,the sensitivity rate and the specificity rate were 27 .8% and 86 .5% for DRE ,44 .4% and 59 .5% for TRUS ,77 .8% and 81 .1% for MP-MRI ,two comparison between the three group had statisfically difference(P〈0 .05) .Conclusion MP-MRI has bet-ter detection efficiency .It could obviously reduce the missed diagnosis rate on PCA with PSA in gray zone .
出处 《重庆医学》 CAS CSCD 北大核心 2014年第22期2868-2869,2872,共3页 Chongqing medicine
关键词 前列腺癌 磁共振成像 经直肠超声检查 直肠指检 prostate cancer MRI transrectal uhrasonography direct rectal examination
  • 相关文献

参考文献11

  • 1JemalA,BrayF,Center MM,etal.Globalcancerstatistics[J].CACancerJClin,2011,61(2):69-90.
  • 2李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:172
  • 3FowlerJE,BrooksJ,PandeyP,eta1.Variablehistologyofanastomoticbiopsies withdetectableprostatespecificantigenafterradicalprostatectomy[J].JUrol,1995,153(3Pt21):1011-1014.
  • 4林延双,梁建波,何大光,玉海,李信众,韦华玉,蓝志相,黄延伟,刘刚.联合血清TPSA,TRUS,DRE诊断前列腺癌的临床研究[J].中国男科学杂志,2007,21(3):37-39. 被引量:4
  • 5陈敏,李春媚.前列腺癌磁共振成像诊断要点与临床治疗方案选择[J].磁共振成像,2011,2(3):225-232. 被引量:9
  • 6Vargas HA,AkinO,FranielT,etal.DiffusionweightedendorectalMRimagingat3Tforprostatecancer:tumordetectionandassessmentofaggressiveness[J].Radiol,2011,259(3):775-784.
  • 7SigmundEE,ChoGY,Kim S,etal.Intravoxelincoherentmotionimagingoftumormicroenvironmentinlocallyadvancedbreastcancer[J].MagnReson Med,2011,65(5):1437-1447.
  • 8FranielT,Hamm B,Hricak H.Dynamiccontrastenhancedmagneticresonanceimagingandpharmacokineticmodelsinprostatecancer[J].EurRadiol,2011,21(3):616-626.
  • 9Pang Y,TurkbeyB,Bernardo M,etal.IntravoxelincoherentmotionMRimagingforprostatecancer:anevaluationofperfusionfractionanddiffusioncoefficientderivedfrom different bvalue combinations[J].Magn ResonMed,2013,69(2):553-562.
  • 10HambrockT,SomfordDM,Huisman HJ,etal.Relationshipbetweenapparentdiffusioncoefficientsat3.0-T MRimagingand Gleason gradein peripheralzoneprostatecancer[J].Radiol,2011,259(2):453-461.

二级参考文献25

  • 1王希明,白人驹.前列腺癌分子水平成像:MRSI[J].国外医学(临床放射学分册),2005,28(5):340-343. 被引量:1
  • 2曾洪武,王培军.磁共振扩散加权与弥散张量成像原理分析及比较[J].中国医学影像技术,2005,21(12):1945-1947. 被引量:49
  • 3张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 4李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 5李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 6李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 7Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 8Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 9Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 10Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.

共引文献182

同被引文献73

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部